口服药物在改善不同病因的性方面的比较效果:一个网络元分析
Iris Otero-Luis1, Arturo Martínez-Rodrigo2, Iván Cavero-Redondo3
1CarVasCare Research Group (2023-GRIN-34459), Facultad de Enfermería de Cuenca, Universidad de Castilla-La Mancha, 16002 Cuenca, Spain.
Postgraduate medical journal
|September 30, 2024
概括
埃皮里松,迪亚泽帕姆和巴克洛芬有效地减少了各种原因的性,与安慰剂相比,显著改善了患者的生活质量. 这个网络的元分析提供了对治疗的最佳口服药物选择的见解.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 性严重影响患者的生活质量,并由各种神经疾病引起.
- 以前对治疗的口服药物的研究已经产生了不一致的结果.
- 需要对口服抗性药物进行全面的比较.
研究的目的:
- 进行网络元分析,比较各种口服药物治疗性的疗效.
- 为了评估不同性病因学的药物有效性.
- 为了确定最佳的口服药物疗法来治疗性.
主要方法:
- 在四个数据库中进行了系统的文献搜索,截至2023年11月.
- 使用频率网络元分析来合成数据.
- 使用修改的阿什沃思尺度来评估度.
主要成果:
- 与安慰剂相比,埃佩里松,迪亚泽帕姆和巴克洛芬在性方面显示出统计学上显著的减少.
- 经过修改的阿什沃思量表表明这些药物的疗效优越.
- 具体的疗效指标包括MD: -0.80 (95%CI: -1.42, -0.18) 对于eperisone, -0.68 (95%CI: -1.28, -0.09) 对于diazepam,以及 -0.58 (95%CI: -1.11, -0.06) 对于baclofen.
结论:
- 埃佩里松,西巴姆和巴克洛芬是有效的口服治疗,可以减少性,无论其根本原因是什么.
- 这些药物有可能改善性患者的生活质量.
- 这些发现支持开发针对的病因学特定治疗策略.
关键词:
修改过的阿什沃思尺度.网络元分析 网络元分析口服药物 口服药物性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性等.更多相关视频
07:20Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
1.1K
08:40Isokinetic Robotic Device to Improve Test-Retest and Inter-Rater Reliability for Stretch Reflex Measurements in Stroke Patients with Spasticity
Published on: June 12, 2019
7.4K
相关概念视频
01:29Spasmolytic Agents: Chemical Classification
869
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
869
01:24Centrally Acting Muscle Relaxants: Therapeutic Uses
643
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
643
01:28Classification of Skeletal Muscle Relaxants
2.4K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.4K
01:09Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.2K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.2K
01:31Skeletal Muscle Relaxants: Therapeutic Uses
475
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
475
01:21Skeletal Muscle Relaxants: Adverse Effects
345
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
345